Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Esteban

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|December 20, 2005
Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patientsMaria Buti, John Wong, Miguel Angel Casado, et al.
Pharmacoeconomics|October 21, 2005
Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1Maria Buti, Miguel A Casado, Leslie Fosbrook, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
Applicability of real-time PCR combined with melting curve analysis for the study of hepatitis B virus genome mutationsFrancisco Rodriguez-Frias, Rosendo Jardi, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analoguesMaria Buti, Luisa Roade, Mar Riveiro-Barciela, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2009
Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?Maria Buti, Cecilia Cabrera, Rosendo Jardi, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 yearsRafael Esteban, Raquel Domínguez-Hernández, Helena Cantero, et al.
Frontiers in Public Health|December 24, 2024
A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testingSonia Albertos, Francesc X Majo, Rafael Esteban, et al.
Plos One|December 1, 2022
Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in SpainRafael Esteban, Raquel Domínguez-Hernández, Victoria Martín-Escudero, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 casesMaria Buti, Auristela Valdés, Francisco Sánchez-Avila, et al.
Hepatology (Baltimore, Md.)|March 13, 2016
Baseline HCV-RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut-off pointsMaria Buti, Juan J Sánchez-Ruano, Rosa M Morillas, et al.
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|December 20, 2005
Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patientsMaria Buti, John Wong, Miguel Angel Casado, et al.
Pharmacoeconomics|October 21, 2005
Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1Maria Buti, Miguel A Casado, Leslie Fosbrook, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
Applicability of real-time PCR combined with melting curve analysis for the study of hepatitis B virus genome mutationsFrancisco Rodriguez-Frias, Rosendo Jardi, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analoguesMaria Buti, Luisa Roade, Mar Riveiro-Barciela, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2009
Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?Maria Buti, Cecilia Cabrera, Rosendo Jardi, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 yearsRafael Esteban, Raquel Domínguez-Hernández, Helena Cantero, et al.
Frontiers in Public Health|December 24, 2024
A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testingSonia Albertos, Francesc X Majo, Rafael Esteban, et al.
Plos One|December 1, 2022
Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in SpainRafael Esteban, Raquel Domínguez-Hernández, Victoria Martín-Escudero, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 casesMaria Buti, Auristela Valdés, Francisco Sánchez-Avila, et al.
Hepatology (Baltimore, Md.)|March 13, 2016
Baseline HCV-RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut-off pointsMaria Buti, Juan J Sánchez-Ruano, Rosa M Morillas, et al.
Pageof 23